Todd Druley
MD, PhD
Chief Medical Officer and Pediatric Oncologist
👥Biography 个人简介
Todd Druley investigates pediatric AML genomics and targeted therapy approaches including menin inhibitors (revumenib, SNDX-5613) for KMT2A-rearranged and NPM1-mutant pediatric leukemia. His work has defined molecular subsets of pediatric AML and accelerated clinical development of menin inhibitors in children. He contributes to COG pediatric AML trial design.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Todd Druley 的研究动态
Follow Todd Druley's research updates
留下邮箱，当我们发布与 Todd Druley（Washington University in St Louis）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment